Yasuyuki Nagata

Transcriptional Repression of Cdc25B by IER5 Inhibits the Proliferation of Leukemic Progenitor Cells through NF-YB and p300 in Acute Myeloid Leukemia

Satoki Nakamura, Yasuyuki Nagata, Lin Tan et al. · PLoS ONE · 2011 · 44 citations · Full text

Decreased level of phosphatidylcholine (16:0/20:4) in multiple myeloma cells compared to plasma cells: a single-cell MALDI–IMS approach

Md Amir Hossen, Yasuyuki Nagata, Michihiko Waki et al. · Analytical and Bioanalytical Chemistry · 2015 · 31 citations · Full text

Palmitic acid, verified by lipid profiling using secondary ion mass spectrometry, demonstrates anti-multiple myeloma activity

Yasuyuki Nagata, Itsuko Ishizaki, Michihiko Waki et al. · Leukemia Research · 2015 · 30 citations

Hematological Malignancy, Anti-multiple Myeloma Activity, Medicine +6

Success and limitations of plasma treatment in pregnant women with congenital thrombotic thrombocytopenic purpura

Kazuya Sakai, Yoshihiro Fujimura, Yasuyuki Nagata et al. · Journal of Thrombosis and Haemostasis · 2020 · 30 citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +9

Single-cell time-of-flight secondary ion mass spectrometry reveals that human breast cancer stem cells have significantly lower content of palmitoleic acid compared to their counterpart non-stem cancer cells

Michihiko Waki, Yoshimi Ide, Itsuko Ishizaki et al. · Biochimie · 2014 · 27 citations

Human Cell, Palmitoleic Acid, Breast Oncology +9